Compile Data Set for Download or QSAR
Report error Found 277 Enz. Inhib. hit(s) with all data for entry = 10025
TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 404177BDBM404177((2S,5R)-5-(2-chlorophenyl)-1-(2'-methyl-3'-(methyl...)
Affinity DataEC50: <200nMAssay Description:The assay was used to determine the activity of the compounds of the invention. The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 404179BDBM404179((2S,5R)-5-(2-chlorophenyl)-1-(5'-cyano-2'-methoxy-...)
Affinity DataEC50: <200nMAssay Description:The assay was used to determine the activity of the compounds of the invention. The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 404180BDBM404180((2S,5R)-5-(2-chlorophenyl)-1-(5'-cyano-2'-methyl-[...)
Affinity DataEC50: <200nMAssay Description:The assay was used to determine the activity of the compounds of the invention. The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 404181BDBM404181((2S,5R)-5-(2-chlorophenyl)-1-(4-(4,6-dimethoxypyri...)
Affinity DataEC50: <200nMAssay Description:The assay was used to determine the activity of the compounds of the invention. The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 404182BDBM404182((2S,5R)-5-(2-chlorophenyl)-1-(4-(3,6-dimethoxypyri...)
Affinity DataEC50: <200nMAssay Description:The assay was used to determine the activity of the compounds of the invention. The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 404184BDBM404184((2S,5R)-5-(2-chlorophenyl)-1-(2'-methoxy-4'-(methy...)
Affinity DataEC50: <200nMAssay Description:The assay was used to determine the activity of the compounds of the invention. The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 404185BDBM404185((2S,5R)-1-(4'-acetamido-2'-methoxy-[1,1'-biphenyl]...)
Affinity DataEC50: <200nMAssay Description:The assay was used to determine the activity of the compounds of the invention. The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 404189BDBM404189((2S,5R)-5-(2-fluorophenyl)-1-(2'-methoxy-4'-(methy...)
Affinity DataEC50: <200nMAssay Description:The assay was used to determine the activity of the compounds of the invention. The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 404190BDBM404190((2S,5R)-5-(2,4-difluorophenyl)-1-(4-(2,6-dimethoxy...)
Affinity DataEC50: <200nMAssay Description:The assay was used to determine the activity of the compounds of the invention. The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 404191BDBM404191((2S,5R)-5-(2-chlorophenyl)-1-(3-methoxy-4-(5-metho...)
Affinity DataEC50: <200nMAssay Description:The assay was used to determine the activity of the compounds of the invention. The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 404192BDBM404192((2S,5R)-1-(4'-amino-2'-methoxy-[1,1'-biphenyl]-4-c...)
Affinity DataEC50: <200nMAssay Description:The assay was used to determine the activity of the compounds of the invention. The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 404156BDBM404156((2S,5R)-5-(2-chlorophenyl)-1-(3-methoxy-4-(6-metho...)
Affinity DataEC50: <200nMAssay Description:The assay was used to determine the activity of the compounds of the invention. The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 404170BDBM404170((2S,5R)-5-(2-chlorophenyl)-1-(4-(2,4-dimethoxypyri...)
Affinity DataEC50: <200nMAssay Description:The assay was used to determine the activity of the compounds of the invention. The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 404171BDBM404171((2S,5R)-5-(2-bromophenyl)-1-(2'-methoxy-[1,1'-biph...)
Affinity DataEC50: <200nMAssay Description:The assay was used to determine the activity of the compounds of the invention. The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 404174BDBM404174((2S,5R)-5-(2-chlorophenyl)-1-(3'-cyano-2'-methoxy-...)
Affinity DataEC50: <200nMAssay Description:The assay was used to determine the activity of the compounds of the invention. The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 404176BDBM404176((2S,5R)-1-(3'-amino-2'-methyl-[1,1'-biphenyl]-4-ca...)
Affinity DataEC50: <200nMAssay Description:The assay was used to determine the activity of the compounds of the invention. The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 408723BDBM408723(US10358416, Compound 387 | (2S,5R)-5-(2-chlorophe...)
Affinity DataEC50: <200nMAssay Description:The assay was used to determine the activity of the compounds of the invention. The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 404213BDBM404213((2S,5R)-5-(2-chlorophenyl)-1-(2-fluoro-4'-(methyls...)
Affinity DataEC50: <200nMAssay Description:The assay was used to determine the activity of the compounds of the invention. The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 404214BDBM404214((2S,5R)-5-(2-chlorophenyl)-1-(2-fluoro-3'-(methyls...)
Affinity DataEC50: <200nMAssay Description:The assay was used to determine the activity of the compounds of the invention. The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 404215BDBM404215((2S,5R)-5-(2-chlorophenyl)-1-(2'-cyano-2-fluoro-[1...)
Affinity DataEC50: <200nMAssay Description:The assay was used to determine the activity of the compounds of the invention. The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 404228BDBM404228((2S,5R)-5-(2,3-difluorophenyl)-1-(2'-methoxy-[1,1'...)
Affinity DataEC50: <200nMAssay Description:The assay was used to determine the activity of the compounds of the invention. The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 404229BDBM404229((2S,5R)-5-(2,5-difluorophenyl)-1-(2'-methoxy-[1,1'...)
Affinity DataEC50: <200nMAssay Description:The assay was used to determine the activity of the compounds of the invention. The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 403752BDBM403752((2S,5R)-5-(2-chlorophenyl)-1-(2'-methoxy-[1,1'-bip...)
Affinity DataEC50: <200nMAssay Description:The assay was used to determine the activity of the compounds of the invention. The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 404231BDBM404231((2S,5R)-1-(2'-cyano-4'-methoxy-[1,1'-biphenyl]-4-c...)
Affinity DataEC50: <200nMAssay Description:The assay was used to determine the activity of the compounds of the invention. The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 404195BDBM404195((2S,5R)-5-(2-chlorophenyl)-1-(5'-cyano-2',3'-dimet...)
Affinity DataEC50: <200nMAssay Description:The assay was used to determine the activity of the compounds of the invention. The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 404196BDBM404196((2S,5R)-5-(2-chlorophenyl)-1-(2'-cyano-4',5'-dimet...)
Affinity DataEC50: <200nMAssay Description:The assay was used to determine the activity of the compounds of the invention. The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 404197BDBM404197((2S,5R)-5-(2-chlorophenyl)-1-(3',4',5'-trimethoxy-...)
Affinity DataEC50: <200nMAssay Description:The assay was used to determine the activity of the compounds of the invention. The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 404201BDBM404201((2S,5R)-5-(2-chlorophenyl)-1-(2-fluoro-3',4'-dimet...)
Affinity DataEC50: <200nMAssay Description:The assay was used to determine the activity of the compounds of the invention. The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 404202BDBM404202((2S,5R)-5-(2-chlorophenyl)-1-(4-(2,6-dimethoxypyri...)
Affinity DataEC50: <200nMAssay Description:The assay was used to determine the activity of the compounds of the invention. The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 404203BDBM404203((2S,5R)-5-(2-chlorophenyl)-1-(3-fluoro-4-(6-methox...)
Affinity DataEC50: <200nMAssay Description:The assay was used to determine the activity of the compounds of the invention. The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 404206BDBM404206((2S,5R)-1-(5'-cyano-2'-methoxy-[1,1'-biphenyl]-4-c...)
Affinity DataEC50: <200nMAssay Description:The assay was used to determine the activity of the compounds of the invention. The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 404207BDBM404207((2S,5R)-1-(4-(2,6-dimethoxypyridin-3-yl)-3-fluorob...)
Affinity DataEC50: <200nMAssay Description:The assay was used to determine the activity of the compounds of the invention. The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 404251BDBM404251((2S,5R)-5-(2-chlorophenyl)-1-(4-(4,6-dimethoxypyri...)
Affinity DataEC50: <200nMAssay Description:The assay was used to determine the activity of the compounds of the invention. The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 404253BDBM404253((2S,5R)-5-(2,3-difluorophenyl)-1-(4-(2,4-dimethoxy...)
Affinity DataEC50: <200nMAssay Description:The assay was used to determine the activity of the compounds of the invention. The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 404254BDBM404254((2S,5R)-1-(5'-cyano-2'-methyl-[1,1'-biphenyl]-4-ca...)
Affinity DataEC50: <200nMAssay Description:The assay was used to determine the activity of the compounds of the invention. The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 403763BDBM403763((2S,5R)-5-(2-chlorophenyl)-1-(2'-methyl-[1,1'-biph...)
Affinity DataEC50: <200nMAssay Description:The assay was used to determine the activity of the compounds of the invention. The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 403764BDBM403764((2S,5R)-1-(3-((4-chlorobenzyl)oxy)-5-methoxybenzoy...)
Affinity DataEC50: <200nMAssay Description:The assay was used to determine the activity of the compounds of the invention. The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 403767BDBM403767((2S,5R)-5-(2-chlorophenyl)-1-(2'-fluoro-[1,1'-biph...)
Affinity DataEC50: <200nMAssay Description:The assay was used to determine the activity of the compounds of the invention. The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 403773BDBM403773((2S,5R)-5-(2-chlorophenyl)-1-(4'-methyl-[1,1'-biph...)
Affinity DataEC50: <200nMAssay Description:The assay was used to determine the activity of the compounds of the invention. The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 404236BDBM404236((2S,5R)-1-(2'-chloro-5'-cyano-[1,1'-biphenyl]-4-ca...)
Affinity DataEC50: <200nMAssay Description:The assay was used to determine the activity of the compounds of the invention. The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 403786BDBM403786((2S,5R)-5-(2-chlorophenyl)-1-(3-methoxy-5-phenetho...)
Affinity DataEC50: <200nMAssay Description:The assay was used to determine the activity of the compounds of the invention. The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 404237BDBM404237((2S,5R)-5-(2-chlorophenyl)-1-(2'-cyano-4'-(trifluo...)
Affinity DataEC50: <200nMAssay Description:The assay was used to determine the activity of the compounds of the invention. The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 404240BDBM404240((2S,5R)-5-(2-chlorophenyl)-1-(2'-methyl-3'-(N-meth...)
Affinity DataEC50: <200nMAssay Description:The assay was used to determine the activity of the compounds of the invention. The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 404241BDBM404241((2S,5R)-5-(2-chlorophenyl)-1-(2'-methoxy-4'-(N-met...)
Affinity DataEC50: <200nMAssay Description:The assay was used to determine the activity of the compounds of the invention. The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 404245BDBM404245((2S,5R)-1-(2'-cyano-4'-(trifluoromethyl)-[1,1'-bip...)
Affinity DataEC50: <200nMAssay Description:The assay was used to determine the activity of the compounds of the invention. The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 404247BDBM404247((2S,5R)-1-(2'-chloro-5'-cyano-[1,1'-biphenyl]-4-ca...)
Affinity DataEC50: <200nMAssay Description:The assay was used to determine the activity of the compounds of the invention. The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 404248BDBM404248((2S,5R)-5-(2-chlorophenyl)-1-(4-(3,6-dimethoxypyri...)
Affinity DataEC50: <200nMAssay Description:The assay was used to determine the activity of the compounds of the invention. The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 404249BDBM404249((2S,5R)-5-(2-fluorophenyl)-1-(2'-methyl-3'-(N-meth...)
Affinity DataEC50: <200nMAssay Description:The assay was used to determine the activity of the compounds of the invention. The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 403853BDBM403853((2S,5R)-5-(2-chlorophenyl)-1-(2',5'-dichloro-[1,1'...)
Affinity DataEC50: <200nMAssay Description:The assay was used to determine the activity of the compounds of the invention. The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 403834BDBM403834((2S,5R)-5-(2-chlorophenyl)-1-(6-(2-chlorophenyl)ni...)
Affinity DataEC50: <200nMAssay Description:The assay was used to determine the activity of the compounds of the invention. The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

Displayed 1 to 50 (of 277 total ) | Next | Last >>
Jump to: